{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1195.323","meta":{"versionId":"5","lastUpdated":"2019-01-30T01:00:08.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NJII Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2019-01-30"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1195.323","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1195.323"}],"version":"20190130","name":"ChemotherapyICD10CM","title":"Chemotherapy ICD10CM","status":"active","experimental":false,"date":"2019-01-30T01:00:08-05:00","publisher":"NJII Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Denominator criteria for Plan All-Cause Readmissions measure STARSC21_HEDISPCR.),(Data Element Scope: ICD10CM Codes),(Inclusion Criteria: As define in STARSC21_HEDISPCR.),(Exclusion Criteria: As define in STARSC21_HEDISPCR.)","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"Z51.0","display":"Encounter for antineoplastic radiation therapy"},{"code":"Z51.11","display":"Encounter for antineoplastic chemotherapy"},{"code":"Z51.12","display":"Encounter for antineoplastic immunotherapy"}]}]},"expansion":{"identifier":"urn:uuid:4e3d58dc-3f79-4b97-a7d8-e5650c8e18be","timestamp":"2023-12-10T23:07:55-05:00","total":3,"contains":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"Z51.0","display":"Encounter for antineoplastic radiation therapy"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"Z51.11","display":"Encounter for antineoplastic chemotherapy"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"Z51.12","display":"Encounter for antineoplastic immunotherapy"}]}}